272 related articles for article (PubMed ID: 28868628)
1. Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells.
You Y; Li Y; Li M; Lei M; Wu M; Qu Y; Yuan Y; Chen T; Jiang H
Clin Exp Immunol; 2018 Jan; 191(1):60-73. PubMed ID: 28868628
[TBL] [Abstract][Full Text] [Related]
2. CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition.
Long H; Xiang T; Qi W; Huang J; Chen J; He L; Liang Z; Guo B; Li Y; Xie R; Zhu B
Oncotarget; 2015 Mar; 6(8):5846-59. PubMed ID: 25788271
[TBL] [Abstract][Full Text] [Related]
3. Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-κB-mediated MMP-9 upregulation.
Long H; Xie R; Xiang T; Zhao Z; Lin S; Liang Z; Chen Z; Zhu B
Stem Cells; 2012 Oct; 30(10):2309-19. PubMed ID: 22887854
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling.
Tang S; Xiang T; Huang S; Zhou J; Wang Z; Xie R; Long H; Zhu B
Cancer Lett; 2016 Jun; 376(1):137-47. PubMed ID: 27033454
[TBL] [Abstract][Full Text] [Related]
5. Targeting cytokines secreted by CD4
Ke X; Shen L
Scand J Immunol; 2019 Feb; 89(2):e12736. PubMed ID: 30485902
[TBL] [Abstract][Full Text] [Related]
6. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.
Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
[TBL] [Abstract][Full Text] [Related]
8. C-C Chemokine Receptor Type 5 (CCR5)-Mediated Docking of Transferred Tregs Protects Against Early Blood-Brain Barrier Disruption After Stroke.
Li P; Wang L; Zhou Y; Gan Y; Zhu W; Xia Y; Jiang X; Watkins S; Vazquez A; Thomson AW; Chen J; Yu W; Hu X
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28768648
[TBL] [Abstract][Full Text] [Related]
9. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.
Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B
Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases.
Swamydas M; Ricci K; Rego SL; Dréau D
Cell Adh Migr; 2013; 7(3):315-24. PubMed ID: 23722213
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer.
Xiang T; Long H; He L; Han X; Lin K; Liang Z; Zhuo W; Xie R; Zhu B
Oncogene; 2015 Jan; 34(2):165-76. PubMed ID: 24362529
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells.
Fialová A; Partlová S; Sojka L; Hromádková H; Brtnický T; Fučíková J; Kocián P; Rob L; Bartůňková J; Spíšek R
Int J Cancer; 2013 Mar; 132(5):1070-9. PubMed ID: 22865582
[TBL] [Abstract][Full Text] [Related]
13. The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells.
Akbarzadeh M; Movassaghpour AA; Ghanbari H; Kheirandish M; Fathi Maroufi N; Rahbarghazi R; Nouri M; Samadi N
Sci Rep; 2017 Dec; 7(1):17062. PubMed ID: 29213108
[TBL] [Abstract][Full Text] [Related]
14. Truncated Bid Overexpression Induced by Recombinant Adenovirus Cre/LoxP System Suppresses the Tumorigenic Potential of CD133
Long Q; Zhu W; Zhou J; Wu J; Lu W; Zheng C; Zhou D; Yu L; Yang R
Oncol Res; 2017 Apr; 25(4):595-603. PubMed ID: 27760587
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments.
Raghavan S; Mehta P; Xie Y; Lei YL; Mehta G
J Immunother Cancer; 2019 Jul; 7(1):190. PubMed ID: 31324218
[TBL] [Abstract][Full Text] [Related]
16. Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis.
Sang XB; Sun KX; Wang LL; Chen S; Wu DD; Zong ZH; Zhao Y
Oncol Rep; 2016 Dec; 36(6):3267-3274. PubMed ID: 27748937
[TBL] [Abstract][Full Text] [Related]
17. Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor-Based Immunotherapy and Chemotherapy.
Klapdor R; Wang S; Hacker U; Büning H; Morgan M; Dörk T; Hillemanns P; Schambach A
Hum Gene Ther; 2017 Oct; 28(10):886-896. PubMed ID: 28836469
[TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
[TBL] [Abstract][Full Text] [Related]
19. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.
Facciabene A; Peng X; Hagemann IS; Balint K; Barchetti A; Wang LP; Gimotty PA; Gilks CB; Lal P; Zhang L; Coukos G
Nature; 2011 Jul; 475(7355):226-30. PubMed ID: 21753853
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells.
Nesbeth YC; Martinez DG; Toraya S; Scarlett UK; Cubillos-Ruiz JR; Rutkowski MR; Conejo-Garcia JR
J Immunol; 2010 May; 184(10):5654-62. PubMed ID: 20400704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
